Transcatheter Mitral Valve Replacement (TMVR) Market Analysis | 2022-2026

Market Insights

The Transcatheter Mitral Valve Replacement (TMVR) Market was estimated at US$ 887.3 million in 2020 and is expected to grow at an impressive CAGR of 26% to reach US$ 3,437.5 million by 2026.

Wish to get a free sample? Register Here

What is a Transcatheter Mitral Valve Replacement?

Transcatheter Mitral Valve Replacement (TMVR) is a minimally invasive medical procedure used to treat mitral valve disorders within the heart. Instead of traditional open-heart surgery, TMVR involves inserting a catheter through blood vessels, usually from the groin, and guiding it to the heart. Once in position, a replacement mitral valve is deployed, often using a collapsible prosthetic valve.

This procedure is particularly beneficial for patients who are considered high-risk for traditional surgery. It aims to address issues such as mitral regurgitation or stenosis, improving heart function, and reducing symptoms without the need for extensive surgery and recovery time.

Market Dynamics

The growth of the global transcatheter mitral valve replacement (TMVR) market is primarily driven by an increasing number of people particularly the geriatric population suffering from cardiovascular diseases.

• Growing emphasis on developing technologically advanced solutions in surgical procedures is projected to propel the market growth at a significant rate during the review period.

• Additionally, increasing demand for minimally invasive procedures over open-heart surgeries is also propelling the market growth substantially.

Furthermore, the increasing prevalence of valvular diseases in developing countries owing to changing lifestyles is likely to create lucrative growth opportunities for the players operating in the global TMVR market in the coming years.

COVID-19 Impact

The COVID-19 outbreak did not affect the growth of the Transcatheter mitral valve replacement (TMVR) market as unlike other medical problems treating heart-related problems cannot be postponed. MR is a life-threatening disease and thus, must be treated as and when required.  The American College of Cardiology (ACC) and Society of Cardiac Angiography and Interventions (SCAI) also established guidelines regarding considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic.

Segments Analysis

Application Trends

The market has been segmented into functional mitral regurgitation (FMR) and degenerative mitral regurgitation (DMR).

• The functional mitral regurgitation segment accounted for the largest market share.

• This market growth can be attributed to the increasing number of people suffering from mitral regurgitation (MR).

• Functional mitral valve regurgitation occurs when the left atrium or left ventricle dilates due to which the mitral valve annulus also dilates and prevents the mitral valve leaflets from proper coaptation.

Regional Trends

Geographically, the market in North America accounted for the largest market share of more than 30%

• The market growth can be attributed to the presence of a large number of people suffering from cardiac diseases.

• More than 2.5% of the U.S. population has valvular heart disease, most commonly among adults.

• The market in Asia-Pacific is expected to increase at a healthy CAGR during the review period on account of increasing demand for advanced surgical procedures to treat heart diseases.

Want to know which region offers the best growth opportunities? Register Here

Key Players

The key players operating in the global transcatheter mitral valve replacement (TMVR) market are-

• Abbott Laboratories (The U.S),
• Micro Interventional Devices, Inc. (The U.S),
• Edward Lifesciences Incorporation (The U.S),
• Neovasc Inc. (Canada), Medtronic plc (The U.S),
• Biotronik (Germany), Colibri Heart Valve LLC (The U.S),
• LivaNova, PLC (UK),
• NeoChord, Inc. (The U.S), and
• Coramaze Technologies GmbH (Germany).

Target Audience

Here is the list of the group of customers that the Global Transcatheter Mitral Valve Replacement market hopes to have the greatest opportunity to convert-

• Transcatheter mitral valve replacement (TMVR) Manufacturers
• Suppliers
• Distributors
• Organizations
• Government bodies

Critical Questions Answered in the Report

• What are the key trends in the global transcatheter mitral valve replacement (TMVR) market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the global transcatheter mitral valve replacement (TMVR) market?
• What are the key strategies adopted by the major vendors to lead in the global transcatheter mitral valve replacement (TMVR) market?
• What is the market share of the top vendors?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players).
• SWOT analysis of key players (up to 3 players).

Market Segmentation

• Current market segmentation of any one of the product types by application type.  

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.